Clinical Trials in Baltimore

Showing 11801-11820 of 20,142 trials

Leveraging mHealth Messaging to Promote Adherence in Teens With CKD

NCT03651596

The overall goal of this study is to develop and test effectively framed mobile health (mHealth) messages to promote medication adherence in teens with chronic kidney disease (CKD).

Chronic Kidney DiseasesAdherence, MedicationCommunication

Johns Hopkins University35 participantsStarted Oct 2018

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

NCT01829711

Background: \- Moxetumomab pasudotox is an experimental non-chemotherapy cancer treatment drug. It targets CD22, a molecule on the surface of essentially all hairy cell leukemia cells. Moxetumomab pasudotox binds to CD22, goes into the cell, and releases a toxin which kills the cell. In a phase I trial it had activity in relapsed/refractory hairy cell leukemia with safety profile supporting further clinical study (http://ncbi.nlm.nih.gov/pubmed/22355053). This is a phase III multicenter trial designed to confirm these results.

Leukemia, Hairy Cell

MedImmune LLC80 participantsStarted Apr 2013

Duarte, California, United States • Los Angeles, California, United States • Miami, Florida, United States +31 more locations

Leveraging mHealth Messaging to Promote Adherence in Teens With CKD

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Find Trials by Condition in Baltimore

Helping Veterans With SMI "StayQuit" From Smoking After Inpatient Hospitalization

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

An Integrated Approach to Smoking Cessation in Severe Mental Illness (SMI)

A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin

Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Using tDCS to Enhance Learning of a New Walking Pattern

Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.

Examining New Diagnostic Tests for Acute Kidney Injury After Heart Surgery

Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission